340B Drug Pricing Program
The Health Resources and Services Administration has provided an update on its new 340B Office of Pharmacy Affairs Information System, which includes a new registration system and a new secure pricing system. HRSA said the registration component of the new 340B OPAIS will be released in mid-…
The Health Resources and Services Administration today proposed delaying until July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. The final rule has been subject to multiple delays since January, and most…
On July 13, the CMS released two proposed rules for calendar year 2018: the outpatient prospective payment system /ambulatory surgical center proposed rule and the Medicare physician fee schedule proposed rule.
The exorbitant cost of many prescription drugs threatens providers’ ability to provide life-saving medications for millions of Americans.That is why the 340B Drug Pricing Program, which provides discounts on drugs to some health care providers who serve large numbers of low-income and uninsured…
The House Energy & Commerce Subcommittee on Oversight and Investigations today held a hearing to review the Health Resources and Services Administration’s oversight of the 340B Drug Pricing Program and how the program impacts patients, providers, manufacturers and other stakeholders.
The AHA July 13 criticized proposed deep cuts to how much the Centers for Medicare & Medicaid Services reimburses hospitals for drugs acquired under the 340B Drug Pricing Program and proposes changes to site-neutral payment policies under Section 603 of the 2015 Bipartisan Budget Act.
On July 13, the CMS released two calendar year 2018 proposed rules: the outpatient prospective payment system/ambulatory surgical center proposed rule and the Medicare physician fee schedule proposed rule.
The Centers for Medicare & Medicaid Services today proposed to update hospital outpatient prospective payment system rates by 1.75% in calendar year 2018 compared to CY 2017. The rule also would drastically cut Medicare payment for drugs that are acquired under the 340B Drug Pricing…
Press Release
Statement on Proposed CY 2018 OPPS Rule
Tom Nickels
Executive Vice President
American Hospital Association
July 13, 2017
Today, CMS issued several poorly designed policies that will do real damage to patients’ access to care.